13.03
[1]. Olszewski RT, et al. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J Neurochem. 200 May;8():876-8.
[2]. Yamamoto T, et al. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-3 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci. 200 Jul;20(2):83-.
H302-H31-H31-H33
P261-P26-P270-P271-P280-P302+P32-P30+P30-P30+P31+P338-P330-P362+P36-P03+P233-P0-P01